The introduction of nicotinamide being a nicotine substitution in e-cigarette and smokeless products and solutions signifies a significant regulatory obstacle for that FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to work as a sedative at high dosages6. The statements created by Nicotine River, ECBlend, along w